SEC Form 4 · accession 0001144204-18-013456
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Bendheim
Officer — Exec. VP, Corporate Strategy · Director
Period of report
Mar 5, 2018
Accepted (ET)
Mar 7, 2018 · 9:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Mar 5, 2018 | M | 3,860 | $11.83 | A | 3,860 | D | |
| Class A Common StockF2 | Mar 5, 2018 | S | 3,860 | $40.06 | D | 0 | D | |
| Class A Common Stock | Mar 6, 2018 | M | 100 | $11.83 | A | 100 | D | |
| Class A Common Stock | Mar 6, 2018 | S | 100 | $40.15 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common Stock | $11.83 | Mar 5, 2018 | M | 3,860 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 3,860 | 23,263 | D |
| Option to purchase Common Stock | $11.83 | Mar 6, 2018 | M | 100 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 100 | 23,163 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.15, inclusive.